Clear Thinking with Danny Lieberman
Subscribe
Sign in
Home
Notes
Archive
Leaderboard
About
Latest
Top
Discussions
Baptisms of fire
How human + agents execute a regulatory workflow (not the LinkedIn version)
Feb 26
•
Danny Lieberman
1
From Nonprofit to Neurotech Powerhouse
How Rafa’s Moonshot Is Rewiring Rare Disease Development.
Feb 23
•
Danny Lieberman
1
1
Israel Builds It. Someone Else Keeps It.
The Israeli MedTech ecosystem is world-class at creating value. It’s structurally poor at capturing it.
Feb 18
•
Danny Lieberman
2
1
1
Wiping out the white space in clinical trials
Yendou reduces years of delays in clinical trials
Feb 16
•
Danny Lieberman
WYSIATI
Don't be deceived by appearances. A Bob and Alice anti-pattern.
Feb 12
•
Danny Lieberman
1
Payments, Pain, and Pragmatic AI
Fixing the unsexy but critical operational layer of clinical trials
Feb 9
•
Danny Lieberman
3
1
When founders reject new ideas, strategy dies quietly
A Bob & Alice anti-pattern, revisited
Feb 5
•
Danny Lieberman
2
1
1
January 2026
Design Matters More Than Goals
The Story of Zebra Medical and why you should care if you’re a TechBio CEO
Jan 30
•
Danny Lieberman
3
1
3
My first startup that succeeded
But not for me
Jan 23
•
Danny Lieberman
4
2
1
Stranger in a strange land
How MedTech startups lose the future
Jan 16
•
Danny Lieberman
4
1
1
The problem you don’t know you have
Why X doesn’t work the way you think
Jan 9
•
Danny Lieberman
3
What happened yesterday is easy
Can we prevent bad things from happening tomorrow?
Jan 2
•
Danny Lieberman
3
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
